1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

MedSci

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2008

Location

Shanghai China

Primary Industry

Healthcare IT

About

MedSci is based in China and was founded in 2008. The firm operates as a clinical research and academic translation services online platform that provides accurate digital medical communication solutions. In September 2020, the company raised CNY 100 million in a pre-IPO from returning investor Qiming Venture Partners and new investor Sci-Tron Borui. In April 2023, MedSci was listed on the Hong Kong Stock Exchange. The main products include digital medical communication and digital clinical research, covering categories such as clinical research, professional growth of doctors, multi-channel academic communication and smart healthcare. The company launched a comprehensive Internet platform for doctors, applying big data and artificial intelligence technology to link doctors, patients and pharmaceutical companies to provide accurate digital medical communication solutions. At the level of digital clinical research, MedSci provides total clinical research solutions to reduce costs and improve quality through digital technology.
Current Investors
Qiming Venture Partners, Sci-Tron Borui, Harvest Fund Management

Request a demo to show more

Primary Industry
Healthcare IT
Sub Industries
Healthcare IT
Website
www.medsci.cn
Company Stage
Mature
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.